Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Specific Reversal Agents for Direct Oral Anticoagulants in Neurosurgical Emergencies
Dec 20, 2025, 07:41

Specific Reversal Agents for Direct Oral Anticoagulants in Neurosurgical Emergencies

RPTH Journal shared a post on LinkedIn:

“In emergency neurosurgery, rapid DOAC reversal is critical. This systematic review evaluates perioperative outcomes of idarucizumab and andexanet alfa, highlighting evidence gaps and safety insights.

If you work in hemostasis, neurosurgery, or acute care, this one’s worth a look.

Senior Author: Menno Germans

Title: Specific reversal agents for direct oral anticoagulants in neurosurgical emergencies – a systematic review

Authors: Laura Zeller, Jonas Rohr, Giovanna Brandi, Christoph Globas, Alexander Kaserer, Matthias Greutmann, Tilman Schubert, Jan-Dirk Studt, Katharina Geiling, Luca Regli, Menno R. Germans

Specific Reversal Agents for Direct Oral Anticoagulants in Neurosurgical Emergencies

Never miss hematology news with Hemostasis Today.